Which parts of semiconductor equipment grew faster in the third quarter?

  • Company data tracked by Shenwan Hongyuan show divergent year-over-year growth in front-end equipment revenue in the third quarter of 2026: AMEC, Piotech, and Hwatsing Technology grew 17.2%, 1.8%, and 23.7%, respectively; net profit attributable to parent-company shareholders grew 159.0%, 135.4%, and 53.5%, respectively.
  • Growth was more pronounced in back-end testing and components: Changchuan Technology, Huafeng Measurement & Control, and Jinhaitong recorded year-over-year revenue growth of 53.9%, 51.7%, and 129.6%, respectively, in the third quarter, while FICT and Hengyunchang grew 47.3% and 73.0%. Profit growth was also relatively strong, indicating that some leading companies have progressed from revenue growth to profit realization.

Why could order growth continue into 2027?

  • As of the end of the third quarter of 2026, contract liabilities at 25 companies in the semiconductor equipment sector totaled 23.607 billion yuan, up 11.1% from 21.24 billion yuan at the end of 2025. Contract liabilities represent advance payments received for which performance is still pending; their continued increase as equipment is delivered, accepted, and recognized as revenue provides support for future revenue.
  • Shenwan Hongyuan believes that AI-driven memory demand, together with the iteration of Yangtze Memory’s 3D NAND stack layers and CXMT’s progress on HBM, could drive domestic memory capital expenditure and orders for domestic equipment. The increasing complexity, size, and cooling requirements of AI chips extend testing time and reduce tester efficiency, which also strengthens demand for back-end testing equipment.
  • The key to this continuation of the growth cycle is the realization of downstream capacity expansion: delivery of existing orders generates revenue, while new expansion replenishes orders. If downstream capital expenditure falls short of expectations, both order growth and the continuation of favorable equipment-sector conditions will be affected.

How much room has rising fish oil prices opened up for algal oil substitution?

  • El Niño has affected catch volumes and oil yields: in 2026, the anchovy catch quota in the north-central zone of Peru’s A season fell 36% year over year, with an actual completion rate of 24.6%; the B season was closed to fishing because fish biomass declined and the proportion of juvenile fish was too high. Chile’s annual quota was cut 44%. In August 2026, Peru’s fish oil FOB price was US$7,683 per ton, up 167% from the low level in the same period of 2025.
  • Fish oil and algal oil can substitute for one another in dietary supplements and aquaculture feed, with aquaculture being the main incremental-demand application. Aquaculture accounted for 63% of fish oil consumption in 2024. Huatai estimates that, at algal oil substitution rates of 25%, 50%, and 65%, additional demand would be 34 thousand, 68 thousand, and 89 thousand tons, respectively—well above algal oil consumption of about 20 thousand tons in 2025.
  • Huatai puts the unit DHA price for algal oil at approximately 142 thousand to 355 thousand yuan per ton, compared with approximately 347 thousand yuan per ton for fish oil, indicating that some algal oil products have room to compete on price. Whether substitution demand translates into actual sales also depends on product economics and the pace of customer adoption.

When will Kingdomway’s growth upside become evident, and what constraints does its existing business face?

  • About one-third of the capacity of Kingdomway’s oil project, with total capacity of ten thousand tons, has entered trial production; the remainder is expected to be completed in stages in the fourth quarter of 2026. The first phase, with capacity of 25 thousand tons, of its 100 thousand-ton algal oil Omega-3 project is expected to come on stream in the first or second quarter of 2027. Huatai expects the company’s algal oil sales to rise from 3.8 thousand tons in 2026 to 29.5 thousand tons in 2027, and algal oil revenue to increase from 160 million yuan to 1.25 billion yuan; progress in capacity ramp-up and substitution demand are direct conditions for this ramp-up.
  • Huatai forecasts Kingdomway’s net profit attributable to parent-company shareholders at 370 million, 650 million, and 770 million yuan in 2026–2028, with year-over-year growth of 74.7% in 2027. Meanwhile, in the first half of 2026, the price per ton of CoQ10 fell 14.4% year over year while sales volume rose 15.1%, reflecting a trade-off of price for volume; vitamin A was close to breakeven. Price pressure on traditional raw materials remains, so the profit forecast does not depend solely on incremental algal oil.